Faye Hood was training for a half-marathon in 2017, when the active then-70-year-old received a stomach cancer diagnosis.

While she put her half-marathon goals on hold for stomach cancer treatment, she knew it was exercise that helped her stay otherwise healthy and made her a strong candidate for an aggressive clinical trial involving heated chemotherapy -- also called hyperthermic intraperitoneal perfusion with chemotherapy (HIPEC...